Panagiotis I Georgianos

25PUBLICATIONS
11CO-AUTHORS
Molecular medicineCardiology (incl. cardiovascular diseases)Medical biotechnology diagnostics (incl. biosensors)HaematologyClinical pharmacology and therapeutics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|May 20, 2026
Spironolactone or Finerenone for Cardiovascular and Kidney Protection in Patients with Moderate CKD?

|Mar 30, 2026
Better cardiorenal protection for patients with CKD and type 1 diabetes.

Panagiotis I Georgianos, Athanasios Roumeliotis, Vassilios Liakopoulos

|Mar 28, 2026
Assistive Technologies to Guide the Management of Volume Overload in Hemodialysis Patients: Are They Ready for Implementation in Daily Clinical Practice?

Panagiotis I Georgianos, Vasileios Kamperidis, Christodoula Kourtidou

|Aug 28, 2025
Assessment of Hypertension in Hemodialysis Patients with the Concomitant Use of Peridialytic and Interdialytic Ambulatory Blood Pressure Measurements.

Kallistheni Leonidou, Ioannis Kontogiorgos, Christodoula Kourtidou

|Aug 11, 2025
CONFIDENCE in the safety and efficacy of dual therapy with an SGLT-2 inhibitor and finerenone in patients with chronic kidney disease and type 2 diabetes.

Panagiotis I Georgianos, Theocharis Koufakis, Spyridon Arampatzis

|Aug 07, 2025
Should We Use Renin-Angiotensin-System Inhibitors As a First-Line Therapy for the Management of Hypertension in Patients Receiving Hemodialysis?

Panagiotis I Georgianos, Ioannis Kontogiorgos, Vasilios Vaios

Pageof 5